Skip to content

Up2info.com

News / Analytics / Reviews

  • Stock Market Analysis
  • Corporate News
  • Financial News

Month: January 2024

AT&T: Strong LTV Growth And Impressive Free Cash Flow Performance

Summary: AT&T has shown strong growth in customer lifetime value and impressive free cash flow performance.Q4 2023...

wpadmin
January 31, 2024

Visa: Resilient Business At A Good Price

Summary: Visa is capitalizing on the global shift towards card-based and electronic payments, with a robust business model...

wpadmin
January 31, 2024

Nvidia: Key Implications From AMD’s Q4 Earnings

Summary: Advanced Micro Devices, Inc.'s update about its outlook for AI accelerators indicates strong demand and...

wpadmin
January 31, 2024

DraftKings: A Strong Buy On Sticky Monetization Trends

Summary: DraftKings has grown from a fledgling gambling outfit into a betting juggernaut over the last few years, gaining...

wpadmin
January 31, 2024

Pfizer Is Down 54% From Highs, Now Yields 6.1%

Summary: Pfizer Inc. stock has experienced a significant decline from its all-time high to the lowest price in over 10...

wpadmin
January 31, 2024

Eli Lilly: GLP-1’s Potential In More Indications Should Unlock Significant Value

Summary: I forecast GLP-1 drugs to become the largest-selling pharmaceutical class, with US sales of $150 billion in...

wpadmin
January 31, 2024

VICI Properties: Trading At A Great Value With Promising Long-Term Potential

Summary: VICI Properties is a popular real estate investment trust with eye-catching dividend metrics and high-quality...

wpadmin
January 31, 2024

Mastercard Stock: A Masterful Dividend Compounder

Summary: Mastercard has consistently produced positive annual earnings growth throughout its history.Since its IPO in 2007,...

wpadmin
January 31, 2024

The Better Buy: Tesla Or Toyota? (SA Quant)

Summary: About seven months ago we said Toyota looked like a more attractive investment than Tesla based on SA quant...

wpadmin
January 31, 2024

Pfizer: Reviewing Q4 Earnings, FY24 Guidance – Why I Disagree With The Market

Summary: Pfizer stock is the worst performing among the "Big 8" U.S. pharmaceutical companies across 5, 3, 1 year, and 3m...

wpadmin
January 31, 2024

Posts navigation

Older posts

Powered By WordPress | Newsmagify